Aclaris Therapeutics Inc (ACRS)

05:50 AM

What drives Aclaris Therapeutics Inc. stock priceExceptional growth trajectory - jammulinksnews.com

05:50 AM

11:36 AM

Aclaris Reports Positive Phase 2a Results for ATI-2138 in Atopic Dermatitis Trial - MSN

11:36 AM

03:29 AM

Is Aclaris Therapeutics Inc. a growth stock or a value stockPre Market Picks With High Returns - jammulinksnews.com

03:29 AM

Aug 01, 2025

How many analysts rate Aclaris Therapeutics Inc. as a “Buy”Breakout Stocks Signals For Fast Growth - jammulinksnews.com

Aug 01, 2025

Aug 01, 2025

How volatile is Aclaris Therapeutics Inc. stock compared to the marketBreakout Stocks Watchlist That Work - jammulinksnews.com

Aug 01, 2025

Jul 31, 2025

What is the dividend policy of Aclaris Therapeutics Inc. stockMarket Forecast Opportunities Backed By Experts - jammulinksnews.com

Jul 31, 2025

Jul 31, 2025

Is it the right time to buy Aclaris Therapeutics Inc. stockDaily Trading Report For Consistent Profits - jammulinksnews.com

Jul 31, 2025

Jul 31, 2025

Is Aclaris Therapeutics Inc. stock bottoming outTechnical Screener for High Growth Stocks - Newser

Jul 31, 2025

Jul 31, 2025

Aclaris Therapeutics Taps Veteran Biotech Leader Roland Kolbeck as New Chief Scientific Officer - MSN

Jul 31, 2025

Jul 31, 2025

Is a relief rally coming for Aclaris Therapeutics Inc. holdersTechnical Stock Breakout Predictions Signal Entry Points - metal.it

Jul 31, 2025

Jul 30, 2025

Will Aclaris Therapeutics Inc. outperform the marketRisk Shielded Trade Watch with Analysis - Newser

Jul 30, 2025

Jul 30, 2025

Analysts Boost Healthcare Stocks: Aclaris Therapeutics and Nuvation Bio - AInvest

Jul 30, 2025

Jul 30, 2025

Aclaris Therapeutics Inc. Breaks Below Key Support LevelQuick Gain Stock Watch With Indicators Reviewed - metal.it

Jul 30, 2025

Jul 30, 2025

Aclaris Therapeutics (ACRS) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Jul 30, 2025

Jul 30, 2025

Market reaction to Aclaris Therapeutics Inc.’s recent newsEntry Alert Based on Volume Spikes Detected - metal.it

Jul 30, 2025

Jul 30, 2025

Stock Market Today: US Future Edge Higher Ahead Of FOMC Decision—Meta, Microsoft Earnings In Focus - Benzinga

Jul 30, 2025

Jul 30, 2025

Momentum divergence signals in Aclaris Therapeutics Inc. chartAI Model Forecasting Reversal and Breakout Zones - Newser

Jul 30, 2025

Jul 30, 2025

Aclaris Therapeutics Stock Spikes In After‑Hours Session Following Major Announcement - Benzinga

Jul 30, 2025

Jul 29, 2025

Aclaris Therapeutics Announces Positive Top-Line Results - GlobeNewswire

Jul 29, 2025

Jul 29, 2025

Aclaris Therapeutics stock soars after positive Phase 2a trial results By Investing.com - Investing.com South Africa

Jul 29, 2025

Jul 29, 2025

Aclaris Therapeutics stock soars after positive Phase 2a trial results - Investing.com Australia

Jul 29, 2025

Jul 29, 2025

Aclaris Therapeutics Announces Positive Phase 2a Trial Results - TipRanks

Jul 29, 2025

Jul 29, 2025

Aclaris reports positive results from ATI-2138 atopic dermatitis trial By Investing.com - Investing.com Nigeria

Jul 29, 2025

Jul 29, 2025

Aclaris Therapeutics Announces Positive Top-Line Results from Open-Label Phase 2a Trial of ATI-2138, a Potent and Selective Investigational Inhibitor of ITK and JAK3; Trial Achieves Primary and Key Secondary Endpoints - GlobeNewswire

Jul 29, 2025

Jul 29, 2025

Breakthrough in Atopic Dermatitis: New Drug ATI-2138 Achieves 77% Improvement in Phase 2a Trial - Stock Titan

Jul 29, 2025

Jul 29, 2025

Aclaris Therapeutics Inc. At Decision Level — Rebound or ResistanceSmart Investment Tips Gaining Popularity Among Analysts - metal.it

Jul 29, 2025

Jul 29, 2025

What makes Aclaris Therapeutics Inc. stock price move sharplyBuy Opportunity Forecast for Fast Traders - Newser

Jul 29, 2025

Jul 29, 2025

Why Aclaris Therapeutics Inc. stock attracts strong analyst attentionLong-Term Trend Tracking and Signal Summary - Newser

Jul 29, 2025

Jul 28, 2025

Biopharma firm with big St. Louis operations names new chief scientific officer - The Business Journals

Jul 28, 2025

Jul 28, 2025

What are Aclaris Therapeutics Inc. company’s key revenue driversStay informed with daily expert analysis - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Aclaris Therapeutics Announces Leadership Transition - GlobeNewswire

Jul 28, 2025

Jul 28, 2025

Aclaris Appoints Drug Development Veteran Behind 6 FDA-Approved Antibodies as New CSO - Stock Titan

Jul 28, 2025

Jul 28, 2025

What are analysts’ price targets for Aclaris Therapeutics Inc. in the next 12 monthsOutstanding capital returns - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

Using R and stats models for Aclaris Therapeutics Inc. forecasting Free Smart Trend Trading with Weekly Signals - Newser

Jul 28, 2025

Jul 28, 2025

What is the risk reward ratio of investing in Aclaris Therapeutics Inc. stockHigh-performance stocks for savvy investors - jammulinksnews.com

Jul 28, 2025

Jul 28, 2025

How Resilient Is Aclaris Therapeutics Inc. Stock During Economic DownturnsFree High-Accuracy Stock Picks - metal.it

Jul 28, 2025

Jul 27, 2025

What are the latest earnings results for Aclaris Therapeutics Inc.Capitalize on emerging growth stocks - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Published on: 2025-07-28 01:01:49 - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

Published on: 2025-07-27 19:20:18 - jammulinksnews.com

Jul 27, 2025

Jul 27, 2025

How Efficient Is Aclaris Therapeutics Inc. at Controlling Operating CostsInsider Level Guidance - Newser

Jul 27, 2025

Jul 25, 2025

Aclaris Therapeutics Inc. Stock Analysis and ForecastConsistently high returns - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

What institutions are buying Aclaris Therapeutics Inc. stock nowPhenomenal returns - jammulinksnews.com

Jul 25, 2025

Jul 25, 2025

What analysts say about Aclaris Therapeutics Inc. stockFree Predictions - PrintWeekIndia

Jul 25, 2025

Jul 23, 2025

LENZ Therapeutics Inc. Stock Analysis and ForecastPhenomenal capital appreciation - Autocar Professional

Jul 23, 2025